[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"healthcare-providers\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:healthcare-providers":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100611642","impact-of-vaccine-funding-by-the-national-health-insurance-on-vaccination-coverage-among-patients-targeted-by-current-vaccination-recommendations-and-followed-in-outpatient-consultations-100611642",false,"NCT07243236","Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations","\"Assessment of the Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations in Ile-de-France Region in France\"\"","VAXINOVA","Inclusion Criteria:\n\nFor patients:\n\n1. For the assessment of pneumococcal coverage among patients eligible for this vaccination:\n\n   * Individuals aged 18 years or older,\n   * Individuals followed in outpatient consultations within a department and healthcare institution participating in the project;\n   * Individuals eligible for pneumococcal vaccination against according to current French recommendations,\n   * Individuals meeting the eligibility conditions and receiving care under long-term illness coverage (ALD) or benefiting from complementary universal health coverage (C2S) or state medical aid (AME).\n2. For the assessment of pertussis vaccination among pregnant women:\n\n   * Women aged 18 years or older,\n   * Women who have had at least one follow-up outpatient consultation from 20 weeks of gestation in a maternity ward participating in the project,\n   * Women in the immediate postpartum period (during their maternity stay) who have given birth to one or more live children and delivered after 36 weeks of gestation,\n   * Women who have declared their pregnancy and are covered under maternity insurance (i.e., from the first day of the sixth month of pregnancy until the 12th day after delivery).\n\nFor healthcare professionals: all vaccinating healthcare providers working in a participating department or center.\n\nExclusion Criteria:\n\n* Individuals seen in settings other than outpatient consultations (day hospital, week hospital, conventional hospitalization, International Vaccination Center).",true,"ALL","18 Years",{"count":21,"type":22},2920,"ESTIMATED","OBSERVATIONAL","The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made possible through the establishment of a tripartite agreement between the hospital group, the Île-de-France Regional Health Agency (ARS IDF), and the Primary Health Insurance Fund (CPAM).",[26,27],"Healthcare Providers","Postpartum",[29,30,31],"Vaccine coverage","Vaccine funding within healthcare institutions","Outpatient consultations","RECRUITING","2026-04-02",{"date":35,"type":36},"2026-04-08","ACTUAL",{"date":38,"type":36},"2025-11-19",{"date":40,"type":22},"2027-07",{"name":42,"class":43},"Assistance Publique - Hôpitaux de Paris","OTHER",6]